Bionano Genom (BNGO)

$2.97 0.14 (4.71%)

20:00 EDT BNGO Stock Quote Delayed 30 Minutes

Bionano Genomics Has the Cash to Push for Greatness

By Mark R. Hake, CFA Mar 10, 2021

Bionano Genomics has a massive valuation based on recent capital raises. BNGO stock is fully valued at 108 times forward 2021 sales, even though sales may spike going forward.

Lofty Expectations Are Already Priced Into Bionano Genomics

Bionano Genomics Would Have Been a Great Find Months Ago

It’s Time to Take Profits on Volatile BioNano Genomics Stock and Buy It Back on Dips

Volume:

Previous Close $2.95

Market Cap 8.87M

PE Ratio -0.05

EPS -64.7156

Volume (Avg. Vol.) 80,129

Day's Range $2.81 - $3.12

52-Week Range $2.68 - $72.60

Dividend & Yield N/A (N/A)

BNGO Stock Predictions, Articles, and Bionano Genom News

BioNano Genomics Stock Is Crashing For a Reason

By Louis Navellier and the InvestorPlace Research Staff Feb 25, 2021

BioNano Genomics shares have been big movers, gaining nearly 3,000% over the past three months, then crashing hard on Tuesday.

Investors Should Have BNGO Stock on Their Long-Term Watch List

By Muslim Farooque, InvestorPlace Contributor Feb 25, 2021

BNGO Stock has alot of potential for growth in the long term but its risks currently limit its attractiveness as an investment

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Feb 23, 2021

What did the stock market do today? Here is what you need to know to profit after a stunning turnaround in stocks.

BNGO Stock: What to Know as Bionano Genomics Drops 15% Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Feb 23, 2021

BNGO stock is on the move today without any real company news. Here's what you should know about Bionano Genomics now.

Leverage the Power of Genetics Tech With Bionano Genomics

By David Moadel, InvestorPlace Contributor Feb 22, 2021

BNGO stock is an investment in the future of gene discovery and therapy as Bionano pushes the boundaries of optical genome mapping tech.

BioNano Genomics’ Next Double Won’t Come Easily

By Will Ashworth, InvestorPlace Contributor Feb 16, 2021

Bionano Genomics makes Saphyr, a genome imaging tool. With BNGO stock doubling over the past month, investors should give the company a look.

4 Top Stock Trades for Tuesday: MJ, NWL, CIIC, BNGO

By Bret Kenwell, InvestorPlace Contributor Feb 12, 2021

The Alternative Harvest ETF, CIIC Merger, Newell Brands and Bionano Genomics were our top stock trades for Tuesday. Let's look at the charts.

BNGO Stock: Why Bionano Genomics Shares Rallied 17% Today

By Chris MacDonald, InvestorPlace Contributor Feb 12, 2021

BNGO stock has continued to shoot higher today on a string of good news that has investors excited about this company's long-term prospects.

Bionano Genomics Has a Story That Investors Should Get Behind

By Chris Markoch, InvestorPlace Contributor Feb 12, 2021

BNGO stock is up 280% this year as its story begins to unfold. The stock may cool off, but it looks like there are many chapters to come for the firm.

BioNano Genomics Is in a Perfect Bull-Bear Tug of War

By Josh Enomoto, InvestorPlace Contributor Feb 10, 2021

Among all the biotech pivots toward the novel coronavirus, BNGO stock represents one of the most sensible. But does that mean shares are a buy?

The Sequence to More Highs is Unfolding in BNGO Stock Today

By Chris Tyler, InvestorPlace Contributor Feb 9, 2021

A dazzling BNGO stock has flown under the radar in 2021, but don't expect shares of this newly-minted mid-cap to remain a secret.

BioNano: The Stock Has Gotten Ahead of Itself

By Ian Bezek, InvestorPlace Contributor Feb 9, 2021

BioNano has a promising clinical platform. It needs to generate more revenues before BNGO stock will be worth its current price, however.

BioNano Genomics Takes Advantage of a Spike

By Mark R. Hake, CFA Feb 3, 2021

Bionano Genomics takes advantage of a spike to sell shares at highs. Cash likely represents about 19% of the BNGO stock market capitalization as a result of two capital raises.